Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carole Guillonneau

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
JCI Insight|February 15, 2017
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cellsElodie Picarda, Séverine Bézie, Laetitia Boucault, et al.
Plos Pathogens|April 27, 2012
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitopeAlex T Chen, Markus Cornberg, Stephanie Gras, et al.
European Journal of Immunology|December 2, 2009
Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of AireKatherine Kedzierska, Sophie A Valkenburg, Carole Guillonneau, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8<sup>+</sup> Regulatory T CellsNail Benallegue, Bryan Nicol, Juliette Lasselin, et al.
Plos Pathogens|August 17, 2010
Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation thresholdSophie A Valkenburg, Stephanie Gras, Carole Guillonneau, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunityCarole Guillonneau, Justine D Mintern, François-Xavier Hubert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejectionCarole Guillonneau, Cédric Louvet, Karine Renaudin, et al.
Frontiers in Immunology|February 16, 2018
<i>Ex Vivo</i> Expanded Human Non-Cytotoxic CD8<sup>+</sup>CD45RC<sup>low/-</sup> Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized MiceSéverine Bézie, Dimitri Meistermann, Laetitia Boucault, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
First-in-class anti-human CD45RC antibody targets CD45RC<sup>high</sup> T and B cells to mitigate pathogenic immune responsesCécile Bergua, Ghenima Ahmil-Boiteau, Laure-Hélène Ouisse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A virusesAlice E Denton, Robb Wesselingh, Stephanie Gras, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
JCI Insight|February 15, 2017
Transient antibody targeting of CD45RC induces transplant tolerance and potent antigen-specific regulatory T cellsElodie Picarda, Séverine Bézie, Laetitia Boucault, et al.
Plos Pathogens|April 27, 2012
Loss of anti-viral immunity by infection with a virus encoding a cross-reactive pathogenic epitopeAlex T Chen, Markus Cornberg, Stephanie Gras, et al.
European Journal of Immunology|December 2, 2009
Diversity and clonotypic composition of influenza-specific CD8+ TCR repertoires remain unaltered in the absence of AireKatherine Kedzierska, Sophie A Valkenburg, Carole Guillonneau, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 20, 2022
Patients With Severe Multiple Sclerosis Exhibit Functionally Altered CD8<sup>+</sup> Regulatory T CellsNail Benallegue, Bryan Nicol, Juliette Lasselin, et al.
Plos Pathogens|August 17, 2010
Protective efficacy of cross-reactive CD8+ T cells recognising mutant viral epitopes depends on peptide-MHC-I structural interactions and T cell activation thresholdSophie A Valkenburg, Stephanie Gras, Carole Guillonneau, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 13, 2009
Combined NKT cell activation and influenza virus vaccination boosts memory CTL generation and protective immunityCarole Guillonneau, Justine D Mintern, François-Xavier Hubert, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2004
The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejectionCarole Guillonneau, Cédric Louvet, Karine Renaudin, et al.
Frontiers in Immunology|February 16, 2018
<i>Ex Vivo</i> Expanded Human Non-Cytotoxic CD8<sup>+</sup>CD45RC<sup>low/-</sup> Tregs Efficiently Delay Skin Graft Rejection and GVHD in Humanized MiceSéverine Bézie, Dimitri Meistermann, Laetitia Boucault, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 1, 2025
First-in-class anti-human CD45RC antibody targets CD45RC<sup>high</sup> T and B cells to mitigate pathogenic immune responsesCécile Bergua, Ghenima Ahmil-Boiteau, Laure-Hélène Ouisse, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 1, 2011
Affinity thresholds for naive CD8+ CTL activation by peptides and engineered influenza A virusesAlice E Denton, Robb Wesselingh, Stephanie Gras, et al.
Pageof 7